Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
November 12, 2026 1.956
November 11, 2026 1.979
November 10, 2026 1.978
November 09, 2026 1.991
November 06, 2026 1.940
November 05, 2026 1.905
November 04, 2026 1.988
November 03, 2026 1.944
November 02, 2026 1.945
October 30, 2026 1.981
October 29, 2026 1.95
October 28, 2026 1.906
October 27, 2026 1.974
October 26, 2026 1.970
October 23, 2026 1.958
October 22, 2026 1.983
October 21, 2026 1.882
October 20, 2026 1.899
October 19, 2026 1.824
October 16, 2026 1.817
October 15, 2026 1.838
October 14, 2026 1.819
October 13, 2026 1.788
October 12, 2026 1.792
October 09, 2026 1.763
Date Value
October 08, 2026 1.706
October 07, 2026 1.735
October 06, 2026 1.741
October 05, 2026 1.746
October 02, 2026 1.718
October 01, 2026 1.740
September 30, 2026 1.764
September 29, 2026 1.779
September 28, 2026 1.792
September 25, 2026 1.784
September 24, 2026 1.774
September 23, 2026 1.783
September 22, 2026 1.766
September 21, 2026 1.717
September 18, 2026 1.689
September 17, 2026 1.717
September 16, 2026 1.693
September 15, 2026 1.694
September 14, 2026 1.703
September 11, 2026 1.702
September 10, 2026 1.688
September 09, 2026 1.651
September 08, 2026 1.665
September 04, 2026 1.730
September 03, 2026 1.759

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
AbbVie, Inc. --
Gilead Sciences, Inc. 15.99
Amgen, Inc. 17.60
Regeneron Pharmaceuticals, Inc. 2.936
Eli Lilly & Co. 33.36

Price to Book Value Related Metrics